NM_153614.4:c.882C>T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_153614.4(DNAJB13):​c.882C>T​(p.Phe294Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.289 in 1,609,274 control chromosomes in the GnomAD database, including 68,644 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6202 hom., cov: 32)
Exomes 𝑓: 0.29 ( 62442 hom. )

Consequence

DNAJB13
NM_153614.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.10

Publications

21 publications found
Variant links:
Genes affected
DNAJB13 (HGNC:30718): (DnaJ heat shock protein family (Hsp40) member B13) This gene encodes a member of the heat shock protein 40 co-chaperone family which is produced in large amounts in the testis and is located on the radial spokes of the axoneme in human sperm flagella and other flagellar structures. The encoded protein associates with the sperm annulus, as part of the septin complex, through direct interaction with septin 4, during sperm terminal differentiation. Naturally occurring mutations in this gene are associated with primary ciliary dyskinesia and male infertility. [provided by RefSeq, Apr 2017]
DNAJB13 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 34
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 11-73970045-C-T is Benign according to our data. Variant chr11-73970045-C-T is described in ClinVar as [Benign]. Clinvar id is 1253105.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.1 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.351 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAJB13NM_153614.4 linkc.882C>T p.Phe294Phe synonymous_variant Exon 8 of 8 ENST00000339764.6 NP_705842.2 P59910-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAJB13ENST00000339764.6 linkc.882C>T p.Phe294Phe synonymous_variant Exon 8 of 8 1 NM_153614.4 ENSP00000344431.1 P59910-1
DNAJB13ENST00000543947.1 linkc.357C>T p.Phe119Phe synonymous_variant Exon 5 of 6 1 ENSP00000438576.1 P59910-2
DNAJB13ENST00000542350.5 linkc.582C>T p.Phe194Phe synonymous_variant Exon 5 of 5 3 ENSP00000440778.1 H0YFX2
DNAJB13ENST00000537753.5 linkc.357C>T p.Phe119Phe synonymous_variant Exon 5 of 5 3 ENSP00000439711.1 P59910-2

Frequencies

GnomAD3 genomes
AF:
0.279
AC:
42433
AN:
151876
Hom.:
6205
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.219
Gnomad AMI
AF:
0.374
Gnomad AMR
AF:
0.358
Gnomad ASJ
AF:
0.294
Gnomad EAS
AF:
0.151
Gnomad SAS
AF:
0.216
Gnomad FIN
AF:
0.310
Gnomad MID
AF:
0.367
Gnomad NFE
AF:
0.305
Gnomad OTH
AF:
0.309
GnomAD2 exomes
AF:
0.285
AC:
69953
AN:
245486
AF XY:
0.282
show subpopulations
Gnomad AFR exome
AF:
0.218
Gnomad AMR exome
AF:
0.367
Gnomad ASJ exome
AF:
0.292
Gnomad EAS exome
AF:
0.129
Gnomad FIN exome
AF:
0.303
Gnomad NFE exome
AF:
0.307
Gnomad OTH exome
AF:
0.304
GnomAD4 exome
AF:
0.290
AC:
422136
AN:
1457280
Hom.:
62442
Cov.:
35
AF XY:
0.288
AC XY:
208524
AN XY:
724702
show subpopulations
African (AFR)
AF:
0.214
AC:
7150
AN:
33396
American (AMR)
AF:
0.370
AC:
16273
AN:
44030
Ashkenazi Jewish (ASJ)
AF:
0.296
AC:
7697
AN:
26036
East Asian (EAS)
AF:
0.177
AC:
7002
AN:
39566
South Asian (SAS)
AF:
0.228
AC:
19395
AN:
85142
European-Finnish (FIN)
AF:
0.305
AC:
16251
AN:
53360
Middle Eastern (MID)
AF:
0.328
AC:
1883
AN:
5746
European-Non Finnish (NFE)
AF:
0.297
AC:
329638
AN:
1109766
Other (OTH)
AF:
0.280
AC:
16847
AN:
60238
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
17107
34214
51322
68429
85536
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10748
21496
32244
42992
53740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.279
AC:
42443
AN:
151994
Hom.:
6202
Cov.:
32
AF XY:
0.279
AC XY:
20689
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.218
AC:
9055
AN:
41466
American (AMR)
AF:
0.359
AC:
5472
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.294
AC:
1018
AN:
3466
East Asian (EAS)
AF:
0.151
AC:
781
AN:
5176
South Asian (SAS)
AF:
0.215
AC:
1037
AN:
4814
European-Finnish (FIN)
AF:
0.310
AC:
3267
AN:
10546
Middle Eastern (MID)
AF:
0.350
AC:
103
AN:
294
European-Non Finnish (NFE)
AF:
0.305
AC:
20727
AN:
67958
Other (OTH)
AF:
0.305
AC:
642
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1569
3138
4707
6276
7845
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
424
848
1272
1696
2120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.300
Hom.:
11665
Bravo
AF:
0.283
Asia WGS
AF:
0.191
AC:
664
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
4.3
DANN
Benign
0.84
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2306819; hg19: chr11-73681090; COSMIC: COSV60104595; COSMIC: COSV60104595; API